Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
Objectives
Extracardiac vascular disease (ECVD) is increasingly recognized as a cardiovascular risk factor, but its association with outcomes after percutaneous coronary intervention (PCI) has not been well characterized.
Methods: Using the National Inpatient Sample database, all patients undergoing PCI between October 2015 and December 2018 were stratified by the presence and organ-specific extent of extracardiac vascular comorbidity (cerebrovascular disease (CeVD), renovascular, aortic and peripheral arterial disease (PAD)). Primary outcome was all-cause mortality and secondary outcomes were (a) major adverse cardiovascular and cerebrovascular events (MACCE), (b) acute ischemic stroke and (c) major bleeding. Multivariable logistic regression was used to determine the adjusted odds ratios (aOR) and 95% confidence interval (95% CI).
Results: Of a total of 1,403,505 patients undergoing PCI during the study period, 199,470 (14.2%) had ECVD. Patients with ECVD were older (median of 72 years vs. 70 years, p < 0.001) and had higher comorbidity burden that their counterparts. All cause-mortality was 22% higher in patients with any ECVD compared to those without ECVD. PAD patients had the highest odds of all-cause mortality (aOR 1.48, 95% CI 1.40–1.56), followed by those with CeVD (aOR 1.15, 95% CI 1.10–1.19). Patients with extracardiac disease had increased odds of MACCE, ischemic stroke and bleeding, irrespective of the nature or extent (p < 0.05), compared to patients without ECVD.
Conclusion: ECVD is associated with worse outcomes in patients undergoing PCI including significantly higher rates of death and stroke. These data should inform our shared decision-making process with our patients.
737-746
Bashar, H
3bb74930-3fec-4284-9847-326611bbf6ad
Matetić, A
ab79dab2-b41e-40e1-88c6-b27a572046aa
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mamas, MA
c742862d-84f9-4625-b264-406a8f6e8533
1 November 2022
Bashar, H
3bb74930-3fec-4284-9847-326611bbf6ad
Matetić, A
ab79dab2-b41e-40e1-88c6-b27a572046aa
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mamas, MA
c742862d-84f9-4625-b264-406a8f6e8533
Bashar, H, Matetić, A, Curzen, Nick and Mamas, MA
(2022)
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
Catheterization and Cardiovascular Interventions, 100 (5), .
(doi:10.1002/ccd.30404).
Abstract
Objectives
Extracardiac vascular disease (ECVD) is increasingly recognized as a cardiovascular risk factor, but its association with outcomes after percutaneous coronary intervention (PCI) has not been well characterized.
Methods: Using the National Inpatient Sample database, all patients undergoing PCI between October 2015 and December 2018 were stratified by the presence and organ-specific extent of extracardiac vascular comorbidity (cerebrovascular disease (CeVD), renovascular, aortic and peripheral arterial disease (PAD)). Primary outcome was all-cause mortality and secondary outcomes were (a) major adverse cardiovascular and cerebrovascular events (MACCE), (b) acute ischemic stroke and (c) major bleeding. Multivariable logistic regression was used to determine the adjusted odds ratios (aOR) and 95% confidence interval (95% CI).
Results: Of a total of 1,403,505 patients undergoing PCI during the study period, 199,470 (14.2%) had ECVD. Patients with ECVD were older (median of 72 years vs. 70 years, p < 0.001) and had higher comorbidity burden that their counterparts. All cause-mortality was 22% higher in patients with any ECVD compared to those without ECVD. PAD patients had the highest odds of all-cause mortality (aOR 1.48, 95% CI 1.40–1.56), followed by those with CeVD (aOR 1.15, 95% CI 1.10–1.19). Patients with extracardiac disease had increased odds of MACCE, ischemic stroke and bleeding, irrespective of the nature or extent (p < 0.05), compared to patients without ECVD.
Conclusion: ECVD is associated with worse outcomes in patients undergoing PCI including significantly higher rates of death and stroke. These data should inform our shared decision-making process with our patients.
This record has no associated files available for download.
More information
e-pub ahead of print date: 21 September 2022
Published date: 1 November 2022
Additional Information:
Bashar H, Matetić A, Curzen N, Mamas MA. Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 Nov;100(5):737-746. doi: 10.1002/ccd.30404. Epub 2022 Sep 21. PMID: 36129816
Identifiers
Local EPrints ID: 492392
URI: http://eprints.soton.ac.uk/id/eprint/492392
ISSN: 1522-1946
PURE UUID: 07f7374d-d3d0-4de9-a7f9-fcf2f4bc7f79
Catalogue record
Date deposited: 25 Jul 2024 16:59
Last modified: 26 Jul 2024 01:40
Export record
Altmetrics
Contributors
Author:
H Bashar
Author:
A Matetić
Author:
MA Mamas
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics